Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT04989257
NA
24-month Ticagrelor-based Dual-antiplatelet Therapy Versus Clopidogrel-based Dual-antiplatelet theRapy aftEr 12 Months of DrUg-eluting Stent Implantation in High isChEmic Risk Patients: P-REDUCE Trial
Sponsor: Yonsei University
View on ClinicalTrials.gov
Summary
The purpose of this prospective randomized clinical trial is to compare the clinical outcomes between aspirin with ticagrelor versus aspirin with clopidogrel in high ischemic risk patients beyond 12 months after percutaneous coronary intervention with drug-eluting stent implantation
Key Details
Gender
All
Age Range
50 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
3488
Start Date
2021-08
Completion Date
2026-06
Last Updated
2021-08-04
Healthy Volunteers
No
Conditions
Interventions
DRUG
Ticagrelor-based dual-antiplatelet therapy
Aspirin with ticagrelor
DRUG
Clopidogrel-based dual-antiplatelet therapy
Aspirin with clopidogrel
Locations (1)
Severance Hospital, Yonsei University Health System
Seoul, South Korea